nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SLCO1A2—Prednisolone—psoriatic arthritis	0.0797	0.0958	CbGbCtD
Quinidine—SLCO1A2—Prednisone—psoriatic arthritis	0.0753	0.0904	CbGbCtD
Quinidine—ABCB11—Dexamethasone—psoriatic arthritis	0.0741	0.089	CbGbCtD
Quinidine—SLCO1A2—Dexamethasone—psoriatic arthritis	0.047	0.0565	CbGbCtD
Quinidine—ABCC2—Dexamethasone—psoriatic arthritis	0.0389	0.0468	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—psoriatic arthritis	0.0378	0.0454	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—psoriatic arthritis	0.0356	0.0428	CbGbCtD
Quinidine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0336	0.0403	CbGbCtD
Quinidine—SLC22A8—Methotrexate—psoriatic arthritis	0.0329	0.0395	CbGbCtD
Quinidine—CYP1A1—Dexamethasone—psoriatic arthritis	0.0325	0.0391	CbGbCtD
Quinidine—ABCC2—Methotrexate—psoriatic arthritis	0.0313	0.0376	CbGbCtD
Quinidine—CYP3A7—Dexamethasone—psoriatic arthritis	0.026	0.0313	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.026	0.0313	CbGbCtD
Quinidine—CYP2E1—Dexamethasone—psoriatic arthritis	0.0251	0.0302	CbGbCtD
Quinidine—CYP2B6—Dexamethasone—psoriatic arthritis	0.0248	0.0298	CbGbCtD
Quinidine—ABCB1—Betamethasone—psoriatic arthritis	0.0218	0.0262	CbGbCtD
Quinidine—ABCB1—Prednisolone—psoriatic arthritis	0.0215	0.0259	CbGbCtD
Quinidine—ABCB1—Prednisone—psoriatic arthritis	0.0203	0.0244	CbGbCtD
Quinidine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0201	0.0242	CbGbCtD
Quinidine—CYP2C8—Dexamethasone—psoriatic arthritis	0.0188	0.0225	CbGbCtD
Quinidine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0152	0.0183	CbGbCtD
Quinidine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0131	0.0157	CbGbCtD
Quinidine—CYP3A4—Betamethasone—psoriatic arthritis	0.0131	0.0157	CbGbCtD
Quinidine—CYP3A4—Prednisolone—psoriatic arthritis	0.0129	0.0155	CbGbCtD
Quinidine—ABCB1—Dexamethasone—psoriatic arthritis	0.0127	0.0153	CbGbCtD
Quinidine—CYP3A4—Prednisone—psoriatic arthritis	0.0122	0.0146	CbGbCtD
Quinidine—CYP2D6—Dexamethasone—psoriatic arthritis	0.012	0.0144	CbGbCtD
Quinidine—ABCB1—Methotrexate—psoriatic arthritis	0.0102	0.0123	CbGbCtD
Quinidine—CYP3A4—Dexamethasone—psoriatic arthritis	0.00761	0.00914	CbGbCtD
Quinidine—Haemorrhage—Betamethasone—psoriatic arthritis	0.000363	0.00216	CcSEcCtD
Quinidine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000363	0.00216	CcSEcCtD
Quinidine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00036	0.00214	CcSEcCtD
Quinidine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000359	0.00214	CcSEcCtD
Quinidine—Ataxia—Methotrexate—psoriatic arthritis	0.000359	0.00214	CcSEcCtD
Quinidine—Vision blurred—Prednisolone—psoriatic arthritis	0.000357	0.00212	CcSEcCtD
Quinidine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000352	0.0021	CcSEcCtD
Quinidine—Visual impairment—Dexamethasone—psoriatic arthritis	0.000349	0.00208	CcSEcCtD
Quinidine—Visual impairment—Betamethasone—psoriatic arthritis	0.000349	0.00208	CcSEcCtD
Quinidine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000349	0.00208	CcSEcCtD
Quinidine—Erythema—Triamcinolone—psoriatic arthritis	0.000348	0.00207	CcSEcCtD
Quinidine—Erythema—Methylprednisolone—psoriatic arthritis	0.000347	0.00207	CcSEcCtD
Quinidine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000347	0.00207	CcSEcCtD
Quinidine—Angioedema—Prednisolone—psoriatic arthritis	0.000346	0.00206	CcSEcCtD
Quinidine—Breast disorder—Methotrexate—psoriatic arthritis	0.000345	0.00205	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000344	0.00205	CcSEcCtD
Quinidine—Vertigo—Prednisolone—psoriatic arthritis	0.00034	0.00202	CcSEcCtD
Quinidine—Syncope—Prednisolone—psoriatic arthritis	0.000339	0.00202	CcSEcCtD
Quinidine—Eye disorder—Dexamethasone—psoriatic arthritis	0.000339	0.00202	CcSEcCtD
Quinidine—Eye disorder—Betamethasone—psoriatic arthritis	0.000339	0.00202	CcSEcCtD
Quinidine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000333	0.00198	CcSEcCtD
Quinidine—Asthma—Methotrexate—psoriatic arthritis	0.00033	0.00196	CcSEcCtD
Quinidine—Convulsion—Prednisolone—psoriatic arthritis	0.000328	0.00195	CcSEcCtD
Quinidine—Bradycardia—Prednisone—psoriatic arthritis	0.000322	0.00191	CcSEcCtD
Quinidine—Angioedema—Triamcinolone—psoriatic arthritis	0.000318	0.00189	CcSEcCtD
Quinidine—Haemoglobin—Prednisone—psoriatic arthritis	0.000317	0.00189	CcSEcCtD
Quinidine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000317	0.00189	CcSEcCtD
Quinidine—Haemorrhage—Prednisone—psoriatic arthritis	0.000316	0.00188	CcSEcCtD
Quinidine—Erythema—Dexamethasone—psoriatic arthritis	0.000316	0.00188	CcSEcCtD
Quinidine—Erythema—Betamethasone—psoriatic arthritis	0.000316	0.00188	CcSEcCtD
Quinidine—Pancytopenia—Methotrexate—psoriatic arthritis	0.000313	0.00186	CcSEcCtD
Quinidine—Vertigo—Triamcinolone—psoriatic arthritis	0.000313	0.00186	CcSEcCtD
Quinidine—Syncope—Triamcinolone—psoriatic arthritis	0.000312	0.00186	CcSEcCtD
Quinidine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000312	0.00186	CcSEcCtD
Quinidine—Syncope—Methylprednisolone—psoriatic arthritis	0.000311	0.00185	CcSEcCtD
Quinidine—Oedema—Prednisolone—psoriatic arthritis	0.000309	0.00184	CcSEcCtD
Quinidine—Neutropenia—Methotrexate—psoriatic arthritis	0.000308	0.00184	CcSEcCtD
Quinidine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000306	0.00182	CcSEcCtD
Quinidine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000305	0.00182	CcSEcCtD
Quinidine—Shock—Prednisolone—psoriatic arthritis	0.000304	0.00181	CcSEcCtD
Quinidine—Convulsion—Triamcinolone—psoriatic arthritis	0.000301	0.00179	CcSEcCtD
Quinidine—Tachycardia—Prednisolone—psoriatic arthritis	0.000301	0.00179	CcSEcCtD
Quinidine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000301	0.00179	CcSEcCtD
Quinidine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000301	0.00179	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000299	0.00178	CcSEcCtD
Quinidine—Myalgia—Triamcinolone—psoriatic arthritis	0.000296	0.00176	CcSEcCtD
Quinidine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000296	0.00176	CcSEcCtD
Quinidine—Eye disorder—Prednisone—psoriatic arthritis	0.000295	0.00176	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000294	0.00175	CcSEcCtD
Quinidine—Flushing—Prednisone—psoriatic arthritis	0.000293	0.00174	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000292	0.00174	CcSEcCtD
Quinidine—Renal failure—Methotrexate—psoriatic arthritis	0.000289	0.00172	CcSEcCtD
Quinidine—Angioedema—Dexamethasone—psoriatic arthritis	0.000288	0.00172	CcSEcCtD
Quinidine—Angioedema—Betamethasone—psoriatic arthritis	0.000288	0.00172	CcSEcCtD
Quinidine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000286	0.0017	CcSEcCtD
Quinidine—Immune system disorder—Prednisone—psoriatic arthritis	0.000285	0.0017	CcSEcCtD
Quinidine—Oedema—Triamcinolone—psoriatic arthritis	0.000284	0.00169	CcSEcCtD
Quinidine—Vertigo—Dexamethasone—psoriatic arthritis	0.000284	0.00169	CcSEcCtD
Quinidine—Vertigo—Betamethasone—psoriatic arthritis	0.000284	0.00169	CcSEcCtD
Quinidine—Syncope—Betamethasone—psoriatic arthritis	0.000283	0.00169	CcSEcCtD
Quinidine—Syncope—Dexamethasone—psoriatic arthritis	0.000283	0.00169	CcSEcCtD
Quinidine—Sweating—Methotrexate—psoriatic arthritis	0.000282	0.00168	CcSEcCtD
Quinidine—Shock—Triamcinolone—psoriatic arthritis	0.000279	0.00166	CcSEcCtD
Quinidine—Shock—Methylprednisolone—psoriatic arthritis	0.000279	0.00166	CcSEcCtD
Quinidine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000278	0.00165	CcSEcCtD
Quinidine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000277	0.00165	CcSEcCtD
Quinidine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000277	0.00165	CcSEcCtD
Quinidine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000277	0.00165	CcSEcCtD
Quinidine—Mental disorder—Prednisone—psoriatic arthritis	0.000277	0.00165	CcSEcCtD
Quinidine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000277	0.00165	CcSEcCtD
Quinidine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000275	0.00164	CcSEcCtD
Quinidine—Erythema—Prednisone—psoriatic arthritis	0.000275	0.00164	CcSEcCtD
Quinidine—Malnutrition—Prednisone—psoriatic arthritis	0.000275	0.00164	CcSEcCtD
Quinidine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000275	0.00163	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000274	0.00163	CcSEcCtD
Quinidine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000274	0.00163	CcSEcCtD
Quinidine—Convulsion—Dexamethasone—psoriatic arthritis	0.000274	0.00163	CcSEcCtD
Quinidine—Convulsion—Betamethasone—psoriatic arthritis	0.000274	0.00163	CcSEcCtD
Quinidine—Myalgia—Dexamethasone—psoriatic arthritis	0.000269	0.0016	CcSEcCtD
Quinidine—Myalgia—Betamethasone—psoriatic arthritis	0.000269	0.0016	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000265	0.00158	CcSEcCtD
Quinidine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000265	0.00158	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000264	0.00157	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—psoriatic arthritis	0.000264	0.00157	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000261	0.00155	CcSEcCtD
Quinidine—Vision blurred—Prednisone—psoriatic arthritis	0.000259	0.00154	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000259	0.00154	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000259	0.00154	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000258	0.00154	CcSEcCtD
Quinidine—Oedema—Betamethasone—psoriatic arthritis	0.000258	0.00153	CcSEcCtD
Quinidine—Oedema—Dexamethasone—psoriatic arthritis	0.000258	0.00153	CcSEcCtD
Quinidine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000254	0.00151	CcSEcCtD
Quinidine—Visual impairment—Methotrexate—psoriatic arthritis	0.000254	0.00151	CcSEcCtD
Quinidine—Shock—Betamethasone—psoriatic arthritis	0.000253	0.00151	CcSEcCtD
Quinidine—Shock—Dexamethasone—psoriatic arthritis	0.000253	0.00151	CcSEcCtD
Quinidine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000253	0.00151	CcSEcCtD
Quinidine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000253	0.0015	CcSEcCtD
Quinidine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000253	0.0015	CcSEcCtD
Quinidine—Agitation—Prednisone—psoriatic arthritis	0.000253	0.0015	CcSEcCtD
Quinidine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000252	0.0015	CcSEcCtD
Quinidine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000252	0.0015	CcSEcCtD
Quinidine—Tachycardia—Betamethasone—psoriatic arthritis	0.000251	0.0015	CcSEcCtD
Quinidine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000251	0.0015	CcSEcCtD
Quinidine—Angioedema—Prednisone—psoriatic arthritis	0.000251	0.0015	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00025	0.00149	CcSEcCtD
Quinidine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000249	0.00148	CcSEcCtD
Quinidine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000249	0.00148	CcSEcCtD
Quinidine—Vertigo—Prednisone—psoriatic arthritis	0.000247	0.00147	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—psoriatic arthritis	0.000247	0.00147	CcSEcCtD
Quinidine—Syncope—Prednisone—psoriatic arthritis	0.000247	0.00147	CcSEcCtD
Quinidine—Tinnitus—Methotrexate—psoriatic arthritis	0.000246	0.00147	CcSEcCtD
Quinidine—Anorexia—Dexamethasone—psoriatic arthritis	0.000246	0.00146	CcSEcCtD
Quinidine—Anorexia—Betamethasone—psoriatic arthritis	0.000246	0.00146	CcSEcCtD
Quinidine—Urticaria—Prednisolone—psoriatic arthritis	0.000245	0.00146	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000245	0.00146	CcSEcCtD
Quinidine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000242	0.00144	CcSEcCtD
Quinidine—Hypotension—Betamethasone—psoriatic arthritis	0.000241	0.00143	CcSEcCtD
Quinidine—Hypotension—Dexamethasone—psoriatic arthritis	0.000241	0.00143	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000238	0.00142	CcSEcCtD
Quinidine—Convulsion—Prednisone—psoriatic arthritis	0.000238	0.00142	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000238	0.00142	CcSEcCtD
Quinidine—Chills—Methotrexate—psoriatic arthritis	0.000237	0.00141	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000235	0.0014	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000235	0.0014	CcSEcCtD
Quinidine—Myalgia—Prednisone—psoriatic arthritis	0.000234	0.00139	CcSEcCtD
Quinidine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000234	0.00139	CcSEcCtD
Quinidine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000233	0.00139	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000232	0.00138	CcSEcCtD
Quinidine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000232	0.00138	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—psoriatic arthritis	0.000231	0.00138	CcSEcCtD
Quinidine—Erythema—Methotrexate—psoriatic arthritis	0.00023	0.00137	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—psoriatic arthritis	0.00023	0.00137	CcSEcCtD
Quinidine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000228	0.00135	CcSEcCtD
Quinidine—Urticaria—Triamcinolone—psoriatic arthritis	0.000226	0.00134	CcSEcCtD
Quinidine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000225	0.00134	CcSEcCtD
Quinidine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000224	0.00134	CcSEcCtD
Quinidine—Oedema—Prednisone—psoriatic arthritis	0.000224	0.00134	CcSEcCtD
Quinidine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000224	0.00133	CcSEcCtD
Quinidine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000224	0.00133	CcSEcCtD
Quinidine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000224	0.00133	CcSEcCtD
Quinidine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000222	0.00132	CcSEcCtD
Quinidine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000222	0.00132	CcSEcCtD
Quinidine—Shock—Prednisone—psoriatic arthritis	0.000221	0.00131	CcSEcCtD
Quinidine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00022	0.00131	CcSEcCtD
Quinidine—Tachycardia—Prednisone—psoriatic arthritis	0.000219	0.0013	CcSEcCtD
Quinidine—Skin disorder—Prednisone—psoriatic arthritis	0.000218	0.0013	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000217	0.00129	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—psoriatic arthritis	0.000217	0.00129	CcSEcCtD
Quinidine—Anorexia—Prednisone—psoriatic arthritis	0.000214	0.00127	CcSEcCtD
Quinidine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000212	0.00126	CcSEcCtD
Quinidine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000212	0.00126	CcSEcCtD
Quinidine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000211	0.00125	CcSEcCtD
Quinidine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000211	0.00125	CcSEcCtD
Quinidine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000209	0.00125	CcSEcCtD
Quinidine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000209	0.00124	CcSEcCtD
Quinidine—Vertigo—Methotrexate—psoriatic arthritis	0.000206	0.00123	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—psoriatic arthritis	0.000206	0.00122	CcSEcCtD
Quinidine—Urticaria—Betamethasone—psoriatic arthritis	0.000205	0.00122	CcSEcCtD
Quinidine—Urticaria—Dexamethasone—psoriatic arthritis	0.000205	0.00122	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000204	0.00122	CcSEcCtD
Quinidine—Dizziness—Prednisolone—psoriatic arthritis	0.000204	0.00122	CcSEcCtD
Quinidine—Asthenia—Triamcinolone—psoriatic arthritis	0.000204	0.00121	CcSEcCtD
Quinidine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000204	0.00121	CcSEcCtD
Quinidine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000204	0.00121	CcSEcCtD
Quinidine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000204	0.00121	CcSEcCtD
Quinidine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000204	0.00121	CcSEcCtD
Quinidine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000203	0.00121	CcSEcCtD
Quinidine—Pruritus—Triamcinolone—psoriatic arthritis	0.000201	0.0012	CcSEcCtD
Quinidine—Pruritus—Methylprednisolone—psoriatic arthritis	0.0002	0.00119	CcSEcCtD
Quinidine—Convulsion—Methotrexate—psoriatic arthritis	0.000199	0.00119	CcSEcCtD
Quinidine—Chest pain—Methotrexate—psoriatic arthritis	0.000196	0.00116	CcSEcCtD
Quinidine—Myalgia—Methotrexate—psoriatic arthritis	0.000196	0.00116	CcSEcCtD
Quinidine—Decreased appetite—Prednisone—psoriatic arthritis	0.000195	0.00116	CcSEcCtD
Quinidine—Rash—Prednisolone—psoriatic arthritis	0.000195	0.00116	CcSEcCtD
Quinidine—Dermatitis—Prednisolone—psoriatic arthritis	0.000195	0.00116	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000194	0.00116	CcSEcCtD
Quinidine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000194	0.00115	CcSEcCtD
Quinidine—Headache—Prednisolone—psoriatic arthritis	0.000193	0.00115	CcSEcCtD
Quinidine—Confusional state—Methotrexate—psoriatic arthritis	0.000189	0.00113	CcSEcCtD
Quinidine—Dizziness—Triamcinolone—psoriatic arthritis	0.000188	0.00112	CcSEcCtD
Quinidine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000187	0.00112	CcSEcCtD
Quinidine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000185	0.0011	CcSEcCtD
Quinidine—Asthenia—Dexamethasone—psoriatic arthritis	0.000185	0.0011	CcSEcCtD
Quinidine—Asthenia—Betamethasone—psoriatic arthritis	0.000185	0.0011	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000184	0.00109	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000184	0.00109	CcSEcCtD
Quinidine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000183	0.00109	CcSEcCtD
Quinidine—Nausea—Prednisolone—psoriatic arthritis	0.000183	0.00109	CcSEcCtD
Quinidine—Pruritus—Betamethasone—psoriatic arthritis	0.000182	0.00109	CcSEcCtD
Quinidine—Pruritus—Dexamethasone—psoriatic arthritis	0.000182	0.00109	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—psoriatic arthritis	0.000182	0.00108	CcSEcCtD
Quinidine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000181	0.00108	CcSEcCtD
Quinidine—Vomiting—Triamcinolone—psoriatic arthritis	0.000181	0.00107	CcSEcCtD
Quinidine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00018	0.00107	CcSEcCtD
Quinidine—Rash—Triamcinolone—psoriatic arthritis	0.000179	0.00107	CcSEcCtD
Quinidine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000179	0.00106	CcSEcCtD
Quinidine—Anorexia—Methotrexate—psoriatic arthritis	0.000179	0.00106	CcSEcCtD
Quinidine—Rash—Methylprednisolone—psoriatic arthritis	0.000179	0.00106	CcSEcCtD
Quinidine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000178	0.00106	CcSEcCtD
Quinidine—Urticaria—Prednisone—psoriatic arthritis	0.000178	0.00106	CcSEcCtD
Quinidine—Headache—Triamcinolone—psoriatic arthritis	0.000178	0.00106	CcSEcCtD
Quinidine—Headache—Methylprednisolone—psoriatic arthritis	0.000177	0.00106	CcSEcCtD
Quinidine—Abdominal pain—Prednisone—psoriatic arthritis	0.000177	0.00106	CcSEcCtD
Quinidine—Body temperature increased—Prednisone—psoriatic arthritis	0.000177	0.00106	CcSEcCtD
Quinidine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000176	0.00105	CcSEcCtD
Quinidine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000176	0.00105	CcSEcCtD
Quinidine—Hypotension—Methotrexate—psoriatic arthritis	0.000175	0.00104	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000171	0.00102	CcSEcCtD
Quinidine—Dizziness—Dexamethasone—psoriatic arthritis	0.00017	0.00101	CcSEcCtD
Quinidine—Dizziness—Betamethasone—psoriatic arthritis	0.00017	0.00101	CcSEcCtD
Quinidine—Nausea—Triamcinolone—psoriatic arthritis	0.000169	0.001	CcSEcCtD
Quinidine—Nausea—Methylprednisolone—psoriatic arthritis	0.000168	0.001	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000167	0.000995	CcSEcCtD
Quinidine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000165	0.000984	CcSEcCtD
Quinidine—Vomiting—Dexamethasone—psoriatic arthritis	0.000164	0.000975	CcSEcCtD
Quinidine—Vomiting—Betamethasone—psoriatic arthritis	0.000164	0.000975	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000163	0.00097	CcSEcCtD
Quinidine—Rash—Betamethasone—psoriatic arthritis	0.000162	0.000967	CcSEcCtD
Quinidine—Rash—Dexamethasone—psoriatic arthritis	0.000162	0.000967	CcSEcCtD
Quinidine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000162	0.000966	CcSEcCtD
Quinidine—Dermatitis—Betamethasone—psoriatic arthritis	0.000162	0.000966	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000162	0.000964	CcSEcCtD
Quinidine—Headache—Betamethasone—psoriatic arthritis	0.000161	0.000961	CcSEcCtD
Quinidine—Headache—Dexamethasone—psoriatic arthritis	0.000161	0.000961	CcSEcCtD
Quinidine—Asthenia—Prednisone—psoriatic arthritis	0.000161	0.000958	CcSEcCtD
Quinidine—Pruritus—Prednisone—psoriatic arthritis	0.000159	0.000945	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000155	0.00092	CcSEcCtD
Quinidine—Diarrhoea—Prednisone—psoriatic arthritis	0.000154	0.000914	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000153	0.000913	CcSEcCtD
Quinidine—Nausea—Betamethasone—psoriatic arthritis	0.000153	0.000911	CcSEcCtD
Quinidine—Nausea—Dexamethasone—psoriatic arthritis	0.000153	0.000911	CcSEcCtD
Quinidine—Urticaria—Methotrexate—psoriatic arthritis	0.000149	0.000887	CcSEcCtD
Quinidine—Dizziness—Prednisone—psoriatic arthritis	0.000148	0.000883	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000148	0.000883	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000148	0.000883	CcSEcCtD
Quinidine—Vomiting—Prednisone—psoriatic arthritis	0.000143	0.000849	CcSEcCtD
Quinidine—Rash—Prednisone—psoriatic arthritis	0.000141	0.000842	CcSEcCtD
Quinidine—Dermatitis—Prednisone—psoriatic arthritis	0.000141	0.000841	CcSEcCtD
Quinidine—Headache—Prednisone—psoriatic arthritis	0.000141	0.000837	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000138	0.000822	CcSEcCtD
Quinidine—Asthenia—Methotrexate—psoriatic arthritis	0.000135	0.000801	CcSEcCtD
Quinidine—Nausea—Prednisone—psoriatic arthritis	0.000133	0.000793	CcSEcCtD
Quinidine—Pruritus—Methotrexate—psoriatic arthritis	0.000133	0.00079	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000128	0.000764	CcSEcCtD
Quinidine—Dizziness—Methotrexate—psoriatic arthritis	0.000124	0.000738	CcSEcCtD
Quinidine—Vomiting—Methotrexate—psoriatic arthritis	0.000119	0.00071	CcSEcCtD
Quinidine—Rash—Methotrexate—psoriatic arthritis	0.000118	0.000704	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—psoriatic arthritis	0.000118	0.000703	CcSEcCtD
Quinidine—Headache—Methotrexate—psoriatic arthritis	0.000117	0.000699	CcSEcCtD
Quinidine—Nausea—Methotrexate—psoriatic arthritis	0.000111	0.000663	CcSEcCtD
